MEDIROM Healthcare Group (MRM) - Price-to-Projected Revenue Ratio

Graphic logo of MEDIROM Corp (MRM)

Compliance with ESG standards and the digitalization of processes at MEDIROM (MRM) reduce environmental risks, which is supported by the forward P/S multiple. The value of 0.10 determines the latest valuation metric, reflecting the business's adaptation to tax conditions. Growth is driven by expansion in Asia and demand for rehabilitation, while dominance in the Japanese manual therapy market combined with proprietary software ensures the stability of its position.

MRM MEDIROM Healthcare Group: Forward Price-to-Revenue Multiple in the range 07/04/2022 - 09/30/2026

Comprehensive metric breakdowns and analytics for MEDIROM Corp (MRM)

- market price and analyst price targets:
Price Chart MEDIROM Healthcare Group|MRM - Fair Value Consensus
- market capitalization indicators:
Market Value MEDIROM Corp|MRM - Total Enterprise Value
- book value of equity indicators:
Net Assets per Single Share MEDIROM|MRM - Company Net Assets|Market Value to Book Value Ratio medirom.co.jp|MRM - Cumulative Company Assets
- debt and liquidity data:
Debt to Equity MEDIROM|MRM - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity MEDIROM|MRM - Company Total Debt|Debt to Book Value MEDIROM Corp|MRM - Amount of Long-Term Liabilities|Company Short-Term Debt MEDIROM|Quick Ratio medirom.co.jp
- business earnings and investment ratios data:
MRM - Company Net Income|Projected Future Earnings MEDIROM|MRM - P/E Multiple|Projected Price to Earnings MEDIROM Healthcare Group Inc|MRM - Company Value to Earnings Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization MEDIROM Corp|MRM - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) MEDIROM|MRM - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months medirom.co.jp|MRM - Earnings per share growth this year|Expected earnings per share growth for next year MEDIROM
- sales and revenue data:
MRM - Company Total Sales|Company Projected Revenue MEDIROM Healthcare Group|MRM - Market Cap to Revenue|Forward P/S Multiple MEDIROM Corp
Analysis of all company metrics:MEDIROM Healthcare Group (MRM)
Original product of MEDIROM

A steady client flow and the subscription-based system of MEDIROM (MRM) ensure high predictability of cash inflows, rendering the business resilient to market volatility. Analyzing the future P/S multiple on GURU.Markets allows for an assessment of the company's current valuation relative to expected revenue, uncovering trader sentiment cycles and identifying entry points for long-term investment in this asset.

Competing companies

Price-to-Projected Revenue Ratio HCA Healthcare HCA|Forward Price to Sales THC|FMS - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Solventum Health|Encompass Health (EHC) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Universal Health Services, Inc.|Price-to-Projected Revenue Ratio DaVita|Forward Price-to-Revenue Multiple RadNet Inc (RDNT)|Price-to-Projected Revenue Ratio Option Care Health Inc (OPCH)|SGRY (Surgery Partners Group) - Forward Price to Sales|Price-to-Projected Revenue Ratio Premier, Inc. PINC|EYE - Forward Price-to-Revenue Multiple|PGNY: Forward Price-to-Revenue Multiple|Ardent Health - Price to Expected Revenue Ratio|Select Medical Corp (SEM) - Price-to-Projected Revenue Ratio|Astrana Corp - Forward Price to Sales|MD (Pediatrix Corp) - Forward P/S Multiple|Market Cap to Future Revenue Ratio US Physical Therapy Inc USPH|Forward P/S Multiple PNTG|Forward P/S Multiple Organogenesis Holdings Inc. (ORGO)|Nutex Health Corp - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio AUNA (Auna Corp)|SBC - Price-to-Projected Revenue Ratio|evolus.com (EOLS) - Forward Price-to-Revenue Multiple|CYH: Forward P/S Multiple|Market Cap to Future Revenue Ratio BeautyHealth (SKIN)|Price-to-Projected Revenue Ratio MediWound Ltd|Market Cap to Projected Revenue BTMD (Biote Corporation)|Forward Price-to-Revenue Multiple JYNT (The Joint Corp.)|Price to Expected Revenue Ratio DCGO|Price-to-Projected Revenue Ratio P3 Health Partners PIII|GANX - Forward Price-to-Revenue Multiple|EUDA Health - Forward P/S Multiple|Market Cap to Future Revenue Ratio Basel Medical Group|CLGN: Forward P/S Multiple|Market Cap to Projected Revenue CUPR|CCM (Concord Medical) - Forward P/S Multiple|American Shared Hospital Services Inc (AMS) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Avalon GloboCare (ALBT)|DHAI (DIH Group) - Forward Price to Sales|Price-to-Projected Revenue Ratio Longevity Health Holdings XAGE|newgenivf.com (NIVF) - Market Cap to Future Revenue Ratio|ATIP - Price-to-Projected Revenue Ratio|CareMax Inc. (CMAX) - Forward Price-to-Revenue Multiple|Kindly MD Corp (KDLY) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple ModivCare Corp|Price-to-Projected Revenue Ratio Novo Integrated Sciences|SSY: Forward Price to Sales|Price-to-Projected Revenue Ratio IMAC Holdings (BACK)